AXL and familial pancreatic carcinoma: Hence, our data reveal an additional novel role of AXL signalling in promoting the regrowth of cancer cells after chemotherapy in established distant lesions, thereby expanding the potential use of AXL inhibitors to fight pancreatic cancer.